Effect of aged garlic extract on APP processing and tau phosphorylation in Alzheimer's transgenic model Tg2576

Journal of Ethnopharmacology

Volumn 108, Issue 3, 2006, Pages 385-394

  Chauhan, Neelima B ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b JESSE BROWN VA MEDICAL CENTER   (United States)

Author keywords

Alzheimer's disease; Amyloid plaques; Cdk5; Di allyl disulfide; Garlic; GSK 3 ; S Allyl cysteine; Tau

Indexed keywords

AMYLOID; ANTIINFLAMMATORY AGENT; CHOLESTEROL; DIALLYL DISULFIDE; GARLIC EXTRACT; S ALLYLCYSTEINE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FEMALE; INFLAMMATION; MALE; MOUSE; NONHUMAN; PHOSPHORYLATION;

ALLYL COMPOUNDS; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BLOTTING, WESTERN; BRAIN; CYSTEINE; DISEASE MODELS, ANIMAL; DISULFIDES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GARLIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEUROPROTECTIVE AGENTS; PHOSPHORYLATION; PLANT EXTRACTS; PROTEIN PROCESSING, POST-TRANSLATIONAL; TAU PROTEINS;

ALLIUM SATIVUM;

EID: 33750606278     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2006.05.030     Document Type: Article

References (60)

1. Alzheimer's Data Base, Nidus Information Services, 2002. FDA Approved Clinical Drug Trials in Alzheimer's Treatment.
2. Auld D.S., Kornecook T.J., Bastianetto S., and Quirion R. Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies. Progresses in Neurobiology 68 (2002) 209-245
3. Balschun D., Wolfer D.P., Gass P., Mantamadiotis T., Welzl H., Schutz G., Frey J.U., and Lipp H.P. Does cAMP response element-binding protein have a pivotal role in hippocampal synaptic plasticity and hippocampus-dependent memory?. Journal of Neuroscience 23 (2003) 6304-6314
4. Benveniste E.N., Nguyen V.T., and Wesemann D.R. Molecular regulation of CD40 gene expression in macrophages and microglia. Brain Behavior Immunnology 18 (2004) 7-12
5. Chauhan N.B. Anti-amyloidogenic effect of Allium sativum in Alzheimer's transgenic model Tg2576. Journal of Herbal Pharmacotherapy 3 (2003) 95-107
6. Chauhan N.B. Multiplicity of garlic health effects and Alzheimer's disease. Journal of Nutrition Health & Aging 9 (2005) 412-432
7. Chauhan N.B., and Siegel G.J. Reversal of amyloid beta toxicity in Alzheimer's disease model Tg2576 by intraventricular antiamyloid beta antibody. Journal of Neuroscience Research 69 (2002) 10-23
8. Chauhan N.B., and Siegel G.J. Effect of PPF and ALCAR on the induction of NGF- and p75-mRNA and on APP processing in Tg2576 brain. Neurochemistry International 43 (2003) 225-233
9. Chauhan N.B., and Siegel G.J. Intracerebroventricular passive immunization with anti-Abeta antibody in Tg2576. Journal of Neuroscience Research 74 (2003) 142-147
10. Chauhan N.B., and Siegel G.J. Intracerebroventricular passive immunization in transgenic mouse models of Alzheimer's disease. Expert Review on Vaccines 3 (2004) 717-725
11. Chauhan N.B., and Siegel G.J. Efficacy of anti-Abeta antibody isotypes used for intracerebroventricular immunization in TgCRND8. Neuroscience Letters 375 (2005) 143-147
12. Chauhan N.B., Siegel G.J., and Lee J.M. Depletion of glial cell line-derived neurotrophic factor in Substantia nigra neurons of Parkinson's disease brain. Journal of Chemical Neuroanatomy 21 (2001) 277-288
13. Chauhan N.B., Lichtor T., and Siegel G.J. Aging potentiates Abeta-induced depletion of SNAP-25 in mouse hippocampus. Brain Research 982 (2003) 219-227
14. Chauhan N.B., Siegel G.J., and Feinstein D.L. Effects of lovastatin and pravastatin on amyloid processing and inflammatory response in TgCRND8 brain. Neurochemical Research 29 (2004) 1897-1911
15. Chauhan N.B., Siegel G.J., and Lichtor T. Effect of age on the duration and extent of amyloid plaque reduction and microglial activation after injection of anti-Abeta antibody into the third ventricle of TgCRND8 mice. Journal of Neuroscience Research 78 (2004) 732-741
16. Chauhan N.B., Siegel G.J., and Feinstein D.L. Propentofylline attenuates tau hyperphosphorylation in Alzheimer's Swedish mutant model Tg2576. Neuropharmacology 48 (2005) 93-104
17. Dineley K.T., Xia X., Bui D., Sweatt J.D., and Zheng H. Accelerated plaque accumulation, associative learning deficits, and up-regulation of alpha 7 nicotinic receptor protein in transgenic mice co-expressing mutant human presenilin 1 and amyloid precursor proteins. Journal of Biological Chemistry 277 (2002) 22768-22780
18. Dirsch V.M., and Vollmar A.M. Ajoene, a natural product with non-steroidal anti-inflammatory drug (NSAID)-like properties?. Biochemical Pharmacology 61 (2001) 587-593
19. Ferrer I., Gomez-Isla T., Puig B., Freixes M., Ribe E., Dalfo E., and Avila J. Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's disease and tauopathies. Current Alzheimer's Research 2 (2005) 3-18
20. Gebhardt R. Inhibition of cholesterol biosynthesis by a water-soluble garlic extract in primary cultures of rat hepatocytes. Arzneimittelforschung 41 (1991) 800-804
21. Gebhardt R., Beck H., and Wagner K.G. Inhibition of cholesterol biosynthesis by Allixin and Ajoene in rat hepatocytes and HepG2 cells. Biochimica et Biophysics Acta 1213 (1994) 57-62
22. Gebhardt R., and Beck H. Differential inhibitory effects of garlic-derived organosulfur compounds on cholesterol biosynthesis in primary rat hepatocyte cultures. Lipids 31 (1996) 1269-1276
23. Geng Z., Rong Y., and Lau B.H. S-Allyl-cysteine inhibits activation of nuclear factor kappa B in human T cells. Free Radical Biololgy & Medicine 23 (1997) 345-350
24. Greenwood J., Walters C.E., Pryce G., Kanuga N., Beraud E., Baker D., and Adamson P. Lovastatin inhibits brain endothelial cell Rho-mediated lymphocyte migration and attenuates experimental autoimmune encephalomyelitis. FASEB Journal 17 (2003) 905-907
25. Hartman T. Cholesterol and Alzheimer's disease: statins, cholesterol depletion in APP processing and Abeta generation. Subcellular Biochemistry 38 (2005) 365-380
26. Hoglund K., Thelen K.M., Syversen S., Sjogren M., von Bergmann K., Wallin A., Vanmechelen E., Vanderstichele H., Lutjohann D., and Blennow K. The effect of simvastatin treatment on the amyloid precursor protein and brain cholesterol metabolism in patients with Alzheimer's disease. Dementia Geriatrics & Cognitive Disorders 19 (2005) 256-265
27. Jacoby R.O., and Fox J.E. Biology and diseases of mice. In: Fx J.G., Cohen B.J., and Loew F.M. (Eds). Laboratory Animal Medicine (1984), Academic Press, Inc., San Diego 84-109
28. Kawarabayashi T., Shoji M., Younkin L.H., Wen-Lang L., Dickson D.W., Murakami T., Matsubara E., Abe K., Ashe K.H., and Younkin S.G. Dimeric amyloid beta protein rapidly accumulates in lipid rafts followed by apolipoprotein E and phosphorylated tau accumulation in the Tg2576 mouse model of Alzheimer's disease. Journal of Neuroscience 24 (2004) 3801-3809
29. Keiss H.P., Dirsch V.M., Hartung T., Haffner T., Trueman L., Auger J., Kahane R., and Vollmar A.M. Garlic (Allium sativum L.) modulates cytokine expression in lipopolysaccharide-activated human blood thereby inhibiting NF-kappaB activity. Journal of Nutrition 133 (2003) 2171-2175
30. Kim K.M., Chun S.B., Koo M.S., Choi W.J., Kim T.W., Kwon Y.G., Chung H.T., Billiar T.R., and Kim Y.M. Differential regulation of NO availability from macrophages and endothelial cells by the garlic component S-allylcysteine. Free Radical Biology Medicine 30 (2001) 747-756
31. Koudinov A.R., and Koudinova N.V. Cholesterol homeostasis failure as a unifying cause of synaptic degeneration. Journal of Neurological Sciences 229/230 (2005) 233-240
32. Lawson L.D., and Gardner C.D. Composition, stability, and bioavailability of garlic products used in a clinical trial. Journal of Agriculture Food & Chemistry 53 (2005) 6254-6261
33. Liu L., and Yeh Y.Y. Inhibition of cholesterol biosynthesis by organosulfur compounds derived from garlic. Lipids 35 (2000) 197-203
34. Liu L., and Yeh Y.Y. S-Alk(en)yl cysteines of garlic inhibit cholesterol synthesis by deactivating HMG-CoA reductase in cultured rat hepatocytes. Journal of Nutrition 132 (2002) 1129-1134
35. Liu S.J., Zhang J.Y., Li H.L., Fang Z.Y., Wang Q., Deng H.M., Gong C.X., Grundke-Iqbal I., Iqba K., and Wang J.Z. Tau becomes a more favorable substrate for GSK-3 when it is prephosphorylated by PKA in rat brain. Journal of Biological Chemistry 279 (2004) 50078-50088
36. Maccioni R.B., Munoz J.P., and Barbeito L. The molecular bases of Alzheimer's disease and other neurodegenerative disorders. Archieves of Medical Research 32 (2001) 367-381
37. Mesulam M., Shaw P., Mash D., and Weintraub S. Cholinergic nucleus basalis tauopathy emerges early in the aging-MCI-AD continuum. Annals of Neurology 55 (2004) 815-828
38. Moriguchi T., Takashina K., Chu P.J., Saito H., and Nishiyama N. Prolongation of life span and improved learning in the senescence accelerated mouse produced by aged garlic extract. Biological Pharmacology Bulletin 17 (1994) 1589-1594
39. Moriguchi T., Saito H., and Nishiyama N. Aged garlic extract prolongs longevity and improves spatial memory deficit in senescence-accelerated mouse. Biological Pharmacology Bulletin 19 (1996) 305-307
40. Nakano H., Kobayashi K., Sugimori K., Shimazaki M., Miyazu K., Hayashi M., and Furuta H. Regional analysis of differently phosphorylated tau proteins in brains from patients with Alzheimer's disease. Dementia, Geriatrics & Cognitive Disorders 17 (2004) 122-131
41. Nishiyama N., Moriguchi T., Morihara N., and Saito H. Ameliorative effect of S-allylcysteine, a major thioallyl constituent in aged garlic extract, on learning deficits in senescence-accelerated mice. Journal of Nutrition 131 (2001) 1093S-1095S
42. Numagami Y., and Ohnishi S.T. S-allylcysteine inhibits free radical production, lipid peroxidation and neuronal damage in rat brain ischemia. Journal of Nutrition 131 (2001) 1100S-1105S
43. Ohm T.G., Treiber-Held S., Distl R., Glockner F., Schonheit B., Tamanai M., and Meske V. Cholesterol and tau protein-findings in Alzheimer's and Niemann Pick C's disease. Pharmacopsychiatry 36 (2003) S120-S126
44. Otth C., Concha I.I., Arendt T., Stieler J., Schliebs R., Gonzalez-Billault C., and Maccioni R.B. AbetaPP induces cdk5-dependent tau hyperphosphorylation in transgenic mice Tg2576. Journal of Alzheimer's Disease 4 (2002) 417-430
45. Parvathy S., Ehrlich M., Pedrini S., Diaz N., Refolo L., Buxbaum J.D., Bogush A., Petanceska S., and Gandy S. Atorvastatin-induced activation of Alzheimer's alpha secretase is resistant to standard inhibitors of protein phosphorylation-regulated ectodomain shedding. Journal of Neurochemistry 90 (2004) 1005-1010
46. Pedrini S., Carter T.L., Prendergast G., Petanceska S., Ehrlich M.E., and Gandy S. Modulation of statin-activated shedding of Alzheimer APP ectodomain by ROCK. PLoS Medicine 2 (2005) e18
47. Rahman A., Akterin S., Flores-Morales A., Crisby M., Kivipelto M., Schultzberg M., and Cedazo-Minguez A. High cholesterol diet induces tau hyperphosphorylation in apolipoprotein E deficient mice. FEBS Letters 579 (2005) 6411-6416
48. Reiss A.B. Cholesterol and apolipoprotein E in Alzheimer's disease. American Journal of Alzheimer's Disease & Other Dementia 20 (2005) 91-96
49. Ryder J., Su Y., Liu F., Li B., Zhou Y., and Ni B. Divergent roles of GSK3 and CDK5 in APP processing. Biochemistry Biophysics Research Communication 312 (2003) 922-929
50. Schwartz I.F., Hershkovitz R., Iaina A., Gnessin E., Wollman Y., Chernichowski T., Blum M., Levo Y., and Schwartz D. Garlic attenuates nitric oxide production in rat cardiac myocytes through inhibition of inducible nitric oxide synthase and the arginine transporter CAT-2 (cationic amino acid transporter-2). Clinical Sciences (London) 102 (2002) 487-493
51. Selkoe D.J. Toward a comprehensive theory for Alzheimer's disease Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein. Annals of New York Academy of Sciences 924 (2000) 17-25
52. Siegel G.J., Chauhan N.B., and Karczmar A.G. Linking amyloid and tau biology in Alzheimer's disease and its cholinergic aspects. In: Karczmar A.G. (Ed). The Rise of Research on the Cholinergic Central Nervous System (2006), Kluwer/Academic Press, New York 569-627
53. Tang B.L. Alzheimer's disease: channeling APP to non-amyloidogenic processing. Biochemistry Biophysics Research Communication 331 (2005) 375-378
54. Tomidokoro Y., Ishiguro K., Harigaya Y., Matsubara E., Ikeda M., Park J.M., Yasutake K., Kawarabayashi T., Okamoto K., and Shoji M. Abeta amyloidosis induces the initial stage of tau accumulation in APP(Sw) mice. Neuroscience Letters 299 (2001) 169-172
55. Townsend K.P., Shytle D.R., Bai Y., San N., Zeng J., Freeman M., Mori T., Fernandez F., Morgan D., Sanberg P., and Tan J. Lovastatin modulation of microglial activation via suppression of functional CD40 expression. Journal of Neuroscience Research 78 (2004) 167-176
56. Vitolo O.V., Sant'Angelo A., Costanzo V., Battaglia F., Arancio O., and Shelanski M. Amyloid beta-peptide inhibition of the PKA/CREB pathway and long-term potentiation: reversibility by drugs that enhance cAMP signaling. Proceedings of National Academy of Sciences of the United States of America 99 (2002) 13217-13221
57. Wang Q., Walsh D.M., Rowan M.J., Selkoe D.J., and Anwyl R. Block of long-term potentiation by naturally secreted and synthetic amyloid beta-peptide in hippocampal slices is mediated via activation of the kinases c-Jun N-terminal kinase, cyclin-dependent kinase 5, and p38 mitogen-activated protein kinase as well as metabotropic glutamate receptor type 5. Journal of Neuroscience 24 (2004) 3370-3378
58. Wargovich M.J. Colon cancer chemoprevention with ginseng and other botanicals. Journal of Korean Medical Sciences 16 (2001) S81-S86
59. Yu W., Ko M., Yanagisawa K., and Michikawa M. Neurodegeneration in heterozygous Niemann-Pick type C1 (NPC1) mouse: implication of heterozygous NPC1 mutations being a risk for tauopathy. Journal of Biological Chemistry 280 (2005) 27296-27302
60. Zheng Y.L., Kesavapany S., Gravell M., Hamilton R.S., Schubert M., Amin N., Albers W., Grant P., and Pant H.C. A Cdk5 inhibitory peptide reduces tau hyperphosphorylation and apoptosis in neurons. EMBO Journal 24 (2005) 209-220